Company Profile
FEMASYS Stock Price, News & Catalysts
- Ticker:
- FEMY
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
2.16 USD (-5.68%)
Close
Last updated: August 17, 2026
22.4M USD
Market cap
Why the stock is moving
Following the latest company update, âFemasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Updateâ, FEMY closed down 5.68% at $2.16 on Aug 17, 2026. The move occurred in the trading session associated with this earnings update.
Company overview
Business overview
Femasys is a womenâs health medical technology company focused on fertility and reproductive-health products. Its business is centered on procedures and devices that address unmet needs in womenâs health.
Geographic Base and Sector Classification
Femasys is headquartered in the United States and listed on NASDAQ. It sits in womenâs-health medtech rather than biotechnology.
Business Model Characteristics
The company depends on product adoption, physician acceptance, and regulatory or commercial milestones. Investors watch launch execution, reimbursement, and the pace of market penetration.
Position Within the Biotechnology Landscape
Femasys occupies a womenâs-health device niche within healthcare innovation. It is not biotech proper, but its growth still depends on product adoption and clinical credibility.
Future catalysts
- Femasysâs catalysts are FemBloc commercialization and womenâs-health product development, where adoption and regulatory progress matter most. The company needs to show the platform can translate into real clinical use.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of FEMASYS (FEMY)?
FEMASYS (FEMY) most recently closed at 2.16 USD, a -5.68% move versus the previous session.
What is the market cap of FEMASYS (FEMY)?
FEMASYS currently has a market capitalization of 22.4M USD on BioPharmSignal.
What does FEMASYS do?
Femasys is a womenâs health medical technology company focused on fertility and reproductive-health products. Its business is centered on procedures and devices that address unmet needs in womenâs health.
On which exchange is FEMY stock listed?
FEMASYS (FEMY) is associated with NASDAQ, United States, Biopharma.
What is Femasys?
Femasysâs catalysts are FemBloc commercialization and womenâs-health product development, where adoption and regulatory progress matter most.
Which conditions is FEMASYS targeting with Femasys?
Femasysâs catalysts are FemBloc commercialization and womenâs-health product development, where adoption and regulatory progress matter most.
How does FEMASYS describe recent progress with Femasys?
Femasysâs catalysts are FemBloc commercialization and womenâs-health product development, where adoption and regulatory progress matter most.
What is FemBloc?
Femasysâs catalysts are FemBloc commercialization and womenâs-health product development, where adoption and regulatory progress matter most.